Mechanisms of cytokine-mediated localized immunoprotection

Journal of Experimental Medicine

Volumn 184, Issue 5, 1996, Pages 1597-1600

  Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE SPECIFICITY;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 2; IMMUNE TOLERANCE; INTERLEUKIN-4; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; T-LYMPHOCYTES; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029845006     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.184.5.1597     Document Type: Article

References (22)

1. Wogensen, L., X. Huang, and N. Sarvetnick. 1993. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin-10 in the islets of Langerhans. J. Exp. Med. 178:175-185.
2. Grewal, I.S., K.D. Grewal, F.S. Wong, D.E. Picarclla, C.A. Janeway, Jr., and R.A. Flavell. 1996. Local expression of transgene encoded TNF-α m islets prevents autoimmune diabetes in NOD mice by preventing the development of autoreactive islet specific T cells. J. Exp. Med. 184:1963-1974.
3. Picarella, D.E., A. Kratz, C. Li, N.H. Ruddle, and R.A. Flavcll. 1993. Transgcnic tumiir nccrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-α and TNF-β transgenic mice. J. Immunol. 150:4136-4150.
4. Guerder, S., J. Meyerhoff, and R. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity. 1:155-166.
5. Wang, B., A. Gonzalez, C. Benoist, and D. Mathis. 1996. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur.J. Immunol 26:1762-1769.
6. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
7. Lo, D., C.R. Reilly, B. Scott, R. Lihlau, H.O. McDevitt, and L.C. Burkly. 1993. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes, Eur. J, Immunol. 23:1693-1698.
8. Higuchi, Y., P. Herrera, P. Muniesa, J. Huarte, D. Belin, P. Ohashi, P. Aichclc, L. Orci, L.-D. Vassalli. and P. Vassalli. 1992. Expression of a tumor necrosis factor ot transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176:1719-1731.
9. Hotamisligil, G.S., D.L. Murray, L.N. Choy, and B.M. Spiegelman. 1994. Tumor necrosis factor α inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91: 4854-4858.
10. Jacob, C.O., S. Aiso, S.A. Michie, H.O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin-1. Proc. Natl. Acad. Sci, USA 87:968-972.
11. Yang, X.-D., R. Tisch, S.M. Singer, Z.A. Cao, R.S. Liblau, R.S. Schreiber, and H.O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995-1004.
12. Lee, M.-S., R. Mueller, L.S. Wicker, L.B. Peterson, and N. Sarvetnick. 1996. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:2663-2668.
13. Pennline, K., E. Roque-Gaffney, and M. Monahan. 1994. Recombinant human IL-10 (rhuIL-10) prevents the onset of diabetes in the nonobese diabetic (NOD) mouse. Clin. Immunol. Immunopathol. 71:169-175.
14. Ranges, G.E., A. Zlotnik, T. Espevik, C.A. Dinarello, A. Cerami, and M.A. Palladino, Jr. 1988. Tumor necrosis factor oi/cachectin is a growth factor tor thymocytes synergistic interactions with other cytokines, J. Exp. Med. 167:1472-1478.
15. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 184:1093-1099.
16. Smith, A.E. 1995. Viral vectors in gene therapy. Ann» Ret>. Microbiol. 49:807-838.
17. Naldini, L., U. Blomcr, P. Gallay, D. Ory, R. Mulligan, F.H. Gage, L.M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (Wash. DC). 272:263-267.
18. Katz, J.D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science (Wash. DC). 268:1185-1188.
19. Sarvetnick, N., J. Shizuru, D. Liggitt, L. Martin, B. McIntyre, A. Gregory, T. Parslow, and T, Stewart. 1990. Loss of pancreatic islet tolerance induced by beta-cell expression of intcrfcron-gamma. Nature (Ijmd.). 346:844-847.
20. Lee, M.-S., M. von Herrath, H. Reiser, M.B.A. Oldstone, and N. Sarvetnick. 1995. Sensitization to self (virus) antigen by in situ expression of murine interferon-γ, J. Clin. Invest. 95:486-492.
21. Gu, D., L. Wogensen, N.A. Calcutt, C. Xia, S. Zhu, J.P. Merlie, H.S. Fox, J. Lindstrom, H.C. Powell, and N. Sarvetnick. 1995. Myasthenia gr avis-like syndrome induced by expression of interferon γ in the neuromuscular junction. J. Exp. Med. 181:547-557.
22. Grabbe, S., S. Bruvers, A.M. Lindgrcn, J. Hosoi, K.C. Tan, and R. Graustem. 1992. Tumor antigen presentation by epidermal antigen-presenting cell in the mouse: modulation by granulocyte-macrophage colony-stimulating factor, tumor nccrosis factor a, and ultraviolet radiation. J. Leukocyte Biol. 52:209-217.